Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Medtronic's diabetes business was a sweet spot in the company's fiscal first quarter of 2024. After FDA approved the company's MiniMed 780G system with the Guardian 4 sensor in April, analysts and ...

Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...

Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems.

Medtronic said Wednesday that it plans to spin off its diabetes business in the next 18 months, creating a new diabetes technology company that can offer customers both insulin pumps and continuous ...